Myriad Acquires Sividon Diagnostics

News   Jun 01, 2016

 
Myriad Acquires Sividon Diagnostics
 
 
 

RELATED ARTICLES

Biomarkers Could Produce Preeclampsia Diagnostic Test

News

Small non-coding RNA analysis may revolutionize how doctors assess preeclampsia risk.

READ MORE

Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease Diagnosis

News

The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.

READ MORE

Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

News

A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE